& zwnj; & zwnj;
|
|
How Protocol Design Drives Comparator Sourcing Cost, Timelines, Complexity and Risk |
|
|
|
|
|
|
|
Learn the appropriate level of detail when designing a study protocol to help avoid common issues that can impact cost, timelines, complexity, and overall risk incurred when sourcing comparators. |
|
|
|
|
|
|
|
Clinical Supply Management |
|
|
|
|
|
|
|
| Is Your Clinical Supply Playbook Ready for Phase II and Beyond? |
| | Listen as clinical supply management and quality experts from Catalent discuss how study characteristics can act as useful leading indicators of future clinical supply challenges. |
| |
|
| Catalent Case Study: Establishing Parameters for Success |
| | Learn how the Catalent CSM team supported a customer to reduce the burden of a complex global study by overcoming inventory challenges to help keep the study on-track. |
| |
|
|
|
|
|
Primary Packaging Strategies |
|
|
|
|
|
|
|
This eBook outlines the primary packaging considerations necessary when developing a clinical supply strategy to ensure GMP compliance at all stages, maintain drug stability, and encourage patient participation and retention. |
|
|
|
|
|
|
|
Every molecule has a challenge. We have a solution. |
| | or call +1 877 891 9609 to speak with one of our experts today! |
| |
|
|
|
|
|
|
To unsubscribe or manage your subscriptions, please click here.
For more information call +1-866-720-3148 or in Europe 00800 88 55 6178, email us at [email protected], or visit our website www.catalent.com. And to learn more about Career opportunities across our global network, visit www.catalent.com/careers. Catalent Pharma Solutions respects your privacy. Links to third party sites are provided as a convenience only. Catalent makes no representation or warranty about the technology, security or any content available at these sites. Links are not intended to imply Catalent's affiliation or endorsement of the website, its owner(s) or the content. © 2020, Catalent Pharma Solutions, Inc. 14 Schoolhouse Road, Somerset, NJ 08873. All rights reserved. |
|
|
|
|
|
|
|
